Massive malaria vaccine trial shows promise for african children
NCT ID NCT03855995
First seen Mar 10, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tested the RTS,S/AS01E malaria vaccine in over 77,000 young children across sub-Saharan Africa. Researchers checked the vaccine's safety and how well it prevents malaria as part of routine childhood shots. The goal is to protect children from this serious disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Kintampo, Ghana
-
GSK Investigational Site
Navrongo, Ghana
-
GSK Investigational Site
Kisumu, 4 0100, Kenya
-
GSK Investigational Site
Kisumu, 40100, Kenya
-
GSK Investigational Site
Chikwawa, Malawi
-
GSK Investigational Site
Mangochi, Malawi
Conditions
Explore the condition pages connected to this study.